Horizon Prevent
Peace of mind begins with knowing.
Genetic cancer prevention from a single blood sample. Modern analysis of circulating tumour DNA looks for genomic alterations that may be detectable before symptoms become apparent.
- A single blood sample
- Expert interpretation
- Consultation with a doctor
AveGene
Exclusive Distribution Partner
- ISO 15189
- Swiss technology
What we build on
Three pillars the programme rests on
Scientific foundation
We work with our international partner AveGene, who develops and provides the genetic analysis technology. Samples are processed within an accredited quality management framework.
A standardised process
From taking the sample through to the results, you are guided by a clearly defined procedure. Sequencing and evaluation follow predefined criteria, so the result does not depend on who processed the sample.
A partner network
We work with doctors, clinics, laboratories, pharmacies and employers.
Horizon Prevent
Genetic prevention that gives you time to act.
Health prevention is at its most valuable when it can flag a risk at a time when a person feels no symptoms at all.
The Horizon Prevent programme combines modern genetic technology with standardised laboratory processing and variant assessment based on internationally recognised classification frameworks. It thus makes it possible to obtain further information that may serve as a basis for a consultation with a doctor.
- A single non-invasive blood sample
- Not limited to one organ
- Accredited laboratory
- Two panels by scope
- A structured report on your results
- Recommendations discussed with a doctor
How the programme works
Five steps from decision to recommendation
The whole process is clearly set out in advance. At every step you know what is happening and what comes next.
- 1
Choosing a programme
You choose the preventive programme that suits you.
- 2
Blood sample
A small amount of blood is taken in a simple procedure.
- 3
Laboratory analysis
The sample is analysed using AveGene technology.
- 4
Evaluation of results
The results are interpreted by specialists.
- 5
Further recommendations
Together with a doctor, you can decide on any further steps.
Who we are here for
Who the programme is for
Prevention makes sense in many different personal and professional situations. Find the one that fits you.
Individuals
You want to take charge of your health and know where you stand before any symptoms appear.
Find out moreFamilies
You are interested in prevention for the whole family, particularly if cancer has already occurred among your relatives.
Find out moreEmployers
You want to offer your people a benefit that makes a real difference to their health.
Find out moreDoctors
You are looking for a complementary tool that broadens the preventive care you can offer your patients.
Find out moreClinics
You want to extend your portfolio of preventive services with a modern genetic programme.
Find out morePharmacies
You want to give your customers access to prevention that goes beyond your usual range.
Find out more
For partners
A partnership built on clear rules
We are building a network of partners who want to offer their clients and patients modern genetic prevention.
We take care of training, materials and support. You focus on what you do best — looking after your clients.
- Team training and professional support
- Marketing materials and documentation
- A distribution portal with an overview of orders
- A straightforward ordering process
- Clear commercial terms
About Horizon Genetic
Prevention that is accessible and easy to understand
Horizon Genetic was founded on a simple conviction — modern genetic prevention should not be the privilege of a select few.
As the official distribution partner for AveGene technology, we bring you a programme that combines an international scientific foundation with care and support in the local language.
You choose a suitable panel, a simple blood sample is taken, the sample is analysed using AveGene technology following standardised procedures, and any variants found are assessed against internationally recognised classification frameworks. You can then discuss the results with your doctor and decide on any further steps.
AveGene offers several screening panels. Two are chosen most often. The Colorectal & Lung Cancer Screening Micro Panel provides focused coverage of 18 oncogenes associated with lung and colorectal malignancies. The Complex Genetic Cancer-Screening Test provides broad coverage of 55 oncogenes and more than 126 oncogenic parameters across multiple malignancies. Processing is identical for both; only the scope differs. Which one suits your situation is something we go through at the consultation.
Conventional screening methods examine one specific part of the body. ctDNA analysis in blood is not tied to a single organ, so from one sample it can provide information relating to malignancies in different tissues. It does not replace those methods, however — it complements them, and recommended screening programmes still need to be attended.
No. Horizon Prevent is a preventive programme designed to complement established screening and diagnostic procedures, not to replace them. It does not establish a diagnosis and does not replace a medical examination. The results serve as a basis for a consultation with a doctor.
The sample is processed using AveGene technology within a quality management framework accredited to ISO 15189. The laboratory procedure, sequencing and bioinformatic evaluation all have predefined quality-control criteria, so the result does not depend on who processed the sample.
We handle personal and health data in line with the GDPR and with legislation on health services. We process data only to the extent necessary to provide the service and do not pass it on to third parties for other purposes.
Next step
Start by asking.
A no-obligation consultation will help you find out whether the Horizon Prevent programme suits you and what you can expect from it.